- George Zimmerman will not be charged in domestic dispute
- Russian officials press bilateral U.S. trade deal
- Selfies at Funerals blog creator retires after Obama flub: ‘Our work here is done’
- New Obama adviser Podesta is against Keystone but will steer clear of pipeline deliberations
- 40 Australian adults, children found in ‘one of the worst accounts of incest ever made public’
- Venezuela’s Maduro calls on student ‘price vigilantes’ to hit the streets, report businesses
- Atheists smug as Hindus join Satanists to demand display at Oklahoma Statehouse
- Bow before Valkyrie, NASA’s ‘superhero robot’ entry in DARPA challenge
- 10-year-old Pennsylvania boy suspended for pretend bow-and-arrow shooting
- Tea partyers turn on Capitol Hill budget deal
Mass. gov. orders surprise pharmacy inspections
Question of the Day
BOSTON (AP) - The governor of Massachusetts is ordering surprise inspections of certain pharmacies after one was linked to a deadly nationwide meningitis outbreak.
Compounding pharmacies specialize in customizing doses for patients who have allergies or need smaller amounts.
A state health department spokesman says the first such inspection was Tuesday. He won’t reveal the name of the facility and says results of the inspection are being reviewed.
Steroid shots from a compounding center just west of Boston are suspected in the meningitis outbreak, which has sickened more than 300 people. Twenty-three people have died.
THIS IS A BREAKING NEWS UPDATE. Check back soon for further information. AP’s earlier story is below.
State officials said Tuesday they found unclean conditions including visible black specks of fungus in steroids and a leaking boiler near what was supposed to be a clean room at a pharmacy linked to a deadly outbreak of meningitis.
Gov. Deval Patrick said the state has moved to revoke the licenses of the New England Compounding Center and three pharmacists there. He also has ordered the state pharmacy board that oversees similar companies to conduct surprise inspections and take other steps to tighten oversight.
State officials said a preliminary investigation found that the NECC shipped orders from the lots of steroid shots suspected in the outbreak before its own tests came back confirming the lots were sterile. In some cases, they said, drugs went out up to 11 days before test results came back.
Officials also said the company, in Framingham, just west of Boston, operated as a drug manufacturer by producing drugs for broader use, rather than filling out specific prescriptions for specific doctors, which is all its license allowed.
The outbreak of meningitis, an inflammation of the lining of the brain and spinal cord, has sickened nearly 300 people, including 23 who died, in more than a dozen states. Each victim had received a steroid shot, mostly for back pain. Federal health officials matched the shots produced by the company to the outbreak after finding a deadly fungus in more than 50 unopened vials there but have not said how the shots were contaminated.
New state documents released this week detailed problems an outside firm hired to do an assessment found there years ago.
The state documents, obtained by The Associated Press under a public records request, say investigators in 2006 found inadequate contamination control and no written standard operating procedures for using equipment, among other problems. The problems were corrected that year, and a state inspection in May 2011 as the company prepared to update its facilities found no such issues.
In a letter sent Monday to a lawyer for NECC, the U.S. House Committee on Energy and Commerce sought nearly 10 years of documents about safety and quality issues at the company. It indicated that as far back as 2002 and 2003 officials from the Food and Drug Administration and the state conducted joint probes of the company after receiving a report about a steroid shot. Those probes preceded a 2004 joint investigation of the center by the FDA and the Massachusetts Board of Registration in Pharmacy.
In January 2006, based on several complaints, the company signed with state regulators a consent agreement in which it agreed to a full inspection of its drug compounding practices by investigators.
By Matt Kibbe
- Rand Paul: Budget deal 'shameful,' 'huge mistake'
- Teen thugs in D.C. run wild -- even while wearing GPS ankle bracelets
- KIBBE: Another Republican budget surrender
- Obama takes 'selfie' at Mandela's funeral service
- Study IDs reasons for late-term abortions
- CARSON: Why did the founders give us the Second Amendment?
- American bourbon now better than Scottish whisky: U.K.-born expert
- VEGAS RULES: Harry Reid pushed feds to change ruling for casino's big-money foreigners
- Biden guarantees victory on immigration reform
- Chinese man fed up with his girlfriend's shopping jumps to his death
Independent voices from the The Washington Times Communities
Interviews and show reviews from the Los Angeles punk scene past and present. Los Angeles has always been rich in punk rock talent since punk rock was born.
Buzz on Bees is a column promoting the love and life of God’s greatest pollinators on earth: The Honeybee
Brazen, leading-edge, “call it like it is” columns and reporting from Ohio native, radio host and writer, Sara Marie Brenner.
A libertarian look at breaking news and political trends by author Tom Mullen.
Extraordinary day at Redskins Park
White House pets gone wild!
Let it snow